Medicine
Indapamide 2.5 mg tablet
Indapamide 2.5 mg tablet is a generic prescription medicine for oral use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Indapamide
- Brand
- Sold under the generic name
- Strength
- 2.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 90 tablets and 10 more
- Manufacturers
- Preferred PharmaceuticalsActavis PharmaBryant Ranch PrepackA-S Medication SolutionsANI PharmaceuticalsDirect_RxGolden State Medical SupplyRising Pharma Holdings
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C03BA11 Indapamide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 July 1995
- Identifiers
- RxCUI 197815, 197816DailyMed set ID deb83f97-6c61-4a09-bed6-18dcf1183405, a8a4ec2c-9d4b-482b-ad29-88185c96db74, 5b55449f-4242-489d-8ba7-5baf4ba1a53a +6NDC 62559-511, 0228-2571, 72162-1767 +6Application ANDA074299, ANDA074722, ANDA074461
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 0228-2571-11 | Actavis Pharma | 2 January 2007 |
| 1000 tablet, film coated in 1 bottle | 0228-2571-96 | Actavis Pharma | 2 January 2007 |
| 100 tablet, film coated in 1 bottle | 62559-511-01 | ANI Pharmaceuticals | 24 April 2017 |
| 100 tablet in 1 bottle | 16571-876-01 | Rising Pharma Holdings | 22 June 2023 |
| 100 tablet, film coated in 1 bottle | 63629-1954-1 | Bryant Ranch Prepack | 29 June 2021 |
| 100 tablet, film coated in 1 bottle | 72162-1767-1 | Bryant Ranch Prepack | 5 October 2023 |
| 90 tablet, film coated in 1 bottle | 50090-7826-1 | A-S Medication Solutions | 16 December 2025 |
| 60 tablet, film coated in 1 bottle | 72189-591-60 | Direct_Rx | 30 October 2024 |
| 100 tablet, film coated in 1 bottle | 51407-025-01 | Golden State Medical Supply | 1 January 2018 |
| 100 tablet, film coated in 1 bottle | 68788-7247-1 | Preferred Pharmaceuticals | 20 August 2018 |
| 30 tablet, film coated in 1 bottle | 68788-7247-3 | Preferred Pharmaceuticals | 20 August 2018 |
| 60 tablet, film coated in 1 bottle | 68788-7247-6 | Preferred Pharmaceuticals | 20 August 2018 |
| 90 tablet, film coated in 1 bottle | 68788-7247-9 | Preferred Pharmaceuticals | 20 August 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 6 July 1983 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Indapamide
Clinical summary
Indapamide is a thiazide-like diuretic indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Indapamide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about IndapamideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Indapamide prescribing information (Rising Pharma Holdings) · U.S. National Library of Medicine, DailyMed
Need Indapamide 2.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.